Adalimumab monotherapy and combination with methotrexate showed similar drug survival and PASI75 response rates in plaque psoriasis patients. Methotrexate reduced antidrug antibody levels but did not ...
In people with psoriasis taking adalimumab, there was no significant difference between adalimumab monotherapy and adalimumab with concomitant methotrexate, according to a recent report in JAMA ...
Share on Facebook. Opens in a new tab or window Share on X. Opens in a new tab or window Share on LinkedIn. Opens in a new tab or window An article published in the Journal of the European Academy of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results